Multiple Myeloma and COVID 19 Webinar

October 20, 2020

Author: Acteropharma

Holding a subspecialty webinar on multiple myeloma management and COVID-19 on May 21st with the presence of prominent professors of medical oncology from Tehran, Dr. Mousavi, Dr. Razavi, Dr. Shahi, from Rasht, Dr. Najafi, from Isfahan, Dr. Ashrafi, simultaneously with the unveiling Bortezomib Acte was administered. This webinar talked about how to manage the treatment of patients with multiple myeloma in the epidemic of COVID-19.

Last News

Actero Support in Congress 1400

July 24, 2022

Author:

Acteropharma

Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

November 16, 2021

Author:

Acteropharma

The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

November 16, 2021

Author:

Acteropharma

Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.